TFA
FLGT icon

Transamerica Financial Advisors’s Fulgent Genetics FLGT Stock Holding History

Transamerica Financial Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$236 – 1990
2025
Q4 		$236 Hold
9
– – ﹤0.01% 1499
2025
Q3 		$203 Buy
+9
New +$185 ﹤0.01% 1440

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Transamerica Financial Advisors's FLGT Position: Q1 2026 in Review

Transamerica Financial Advisors sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 9 shares — an estimated $236 sold.

Transamerica Financial Advisors first reported a position in FLGT in Q3 2025 and held it in 2 quarters. The position peaked at $236 in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Transamerica Financial Advisors reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Transamerica Financial Advisors sold 9 Fulgent Genetics shares in Q1 2026, an estimated $236.
  • Transamerica Financial Advisors first reported a position in Fulgent Genetics in Q3 2025 and held it in 2 quarters.
  • Transamerica Financial Advisors's Fulgent Genetics position peaked at $236 in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.